$4.54
+0.06 (+1.34%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+466.7% upside
Low Target
$18.91
Average Target
$25.73
High Target
$33.51
Current Price
$4.54
Current
$4.54
$4.54
Target
$25.73
$25.73
$18.91
$25.73 avg
$33.51
Scenario Analysis
Bear Case
$18.91
316.5%
Low target
Base Case
$25.73
+466.7%
Avg target
Bull Case
$33.51
+638.1%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$29.98
-84.9% from high
52-Week Low
$4.46
+1.8% from low
Target vs 52W High
$25.73
-14.2% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |